Previous 10 | Next 10 |
home / stock / vphif / vphif news
Valeo Pharma (VPHIF): FQ2 GAAP EPS of -C$0.03.Revenue of C$2.65M (+27.4% Y/Y)Press Release For further details see: Valeo Pharma reports FQ2 results
Valeo Pharma Reports its Second Quarter 2021 Results and Highlights Canada NewsWire Q2-21 record revenues of $2.65 million , up 27% vs Q2-20 and up 42% over prior quarter Q3-21 revenues expected to increase by more than 50% over Q2-21 Rede...
Valeo Pharma Closes $11.5 Million Bought-Deal Public Offering, Including Full Exercise of the Over-Allotment Option Canada NewsWire /NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES / MONTREAL , June 29, 2021 /CNW T...
Valeo Pharma to Report Second Quarter 2021 Results and Hold Investors Conference Call / Webcast Canada NewsWire MONTREAL , June 23, 2021 /CNW Telbec/ - Valeo Pharma Inc . (CSE:VPH) (OTCQB: VPHIF) (FSE:VP2) (" Valeo " or the " Company "), a Canadian ph...
Valeo Pharma Announces Commercial Launch of Enerzair® Breezhaler® and Atectura® Breezhaler® Canada NewsWire Product shipments have commenced across Canada National respiratory sales force recruitment well advanced, field deployment on-...
Valeo Pharma Provides Update on Private Payer Reimbursement for Enerzair® Breezhaler® and Atectura® Breezhaler® Canada NewsWire Private payer health plan coverage in Canada for Enerzair Breezhaler and Atectura Breezhaler has reached 80% ...
Valeo Pharma Projecting Record Revenues for Second Quarter 2021 Canada NewsWire Record revenues and margins expected for Q2-21 Redesca® launch beginning to impact financial performance Respiratory sales force infrastructure well advanced in suppo...
Valeo Pharma Joins Innovative Medecines Canada Canada NewsWire MONTREAL , May 17, 2021 /CNW/ - Valeo Pharma Inc . (CSE: VPH) (OTCQB: VPHIF) (FSE: VP2) (" Valeo " or the " Company "), a Canadian pharmaceutical company, today announced that Valeo has be...
Valeo Pharma Announces Voting Results of its 2021 Annual General and Special Meeting of Shareholders Canada NewsWire MONTREAL , April 29, 2021 /CNW/ - Valeo Pharma Inc . (CSE: VPH) (OTCQB: VPHIF) (FSE: VP2) (" Valeo " or the " Company "), a Canadian p...
Valeo Pharma's Redesca® and Redesca HP® to Be Covered Under the Ontario Public Drug Benefit Program PR Newswire Ontario represents 37% of the Canadian low molecular weight heparin market Additional provincial coverage expected to follow ...
News, Short Squeeze, Breakout and More Instantly...
VALEO PHARMA ANNOUNCES SENIOR EXECUTIVE APPOINTMENT AND BOARD OF DIRECTORS CHANGE Canada NewsWire MONTREAL , June 18, 2024 /CNW/ - Valeo Pharma Inc . (TSX: VPH) (OTCQB: VPHIF) (FSE: VP2) (" Valeo " or the " Company "), a Canadian pharmaceutical compan...
(NewsDirect) Valeo Pharma CEO Steve Saviuk joined Steve Darling from Proactive to discuss the company's financial results for the second quarter, which saw record-breaking revenue for the period. The company reported revenues of $14.1 million for Q2, an increase from the $13.6 million rec...
VALEO PHARMA ANNOUNCES RESTRUCTURING OF COMMERCIAL FIELD OPERATIONS TO SUPPORT PATH TO PROFITABILITY Canada NewsWire Changes to respiratory business unit to generate more than $5 million in annual savings Follows previously announced cost saving measures exce...